Yale epidemiology professor Harvey Risch published an embarrassingly bad op-ed in Newsweek defending hydroxychloroquine to treat COVID-19. It reminded me how much acupuncture and hydroxychloroquine believers have in common.
Recently, Henry Ford Hospital published a study of hydroxychloroquine for COVID-19 that showed a benefit. Unfortunately, it was a bias-prone retrospective study. That didn’t stop President Trump from touting the drug again.
Science by press release is never good. The press release claiming that dexamethasone is effective against severe COVID-19 is no exception.
I got it wrong about something. It turns out that recent Lancet hydroxychloroquine study was likely fraudulent, thanks to a small, very dodgy company called Surgisphere. Here, I admit and explain my error and try to set things right.
A new study of #Hydroxychloroquine and #Chloroquine to treat #COVID19 was published this morning in The Lancet. The results? More deaths and arrhythmias in treated patients. [NOTE ADDENDUM: This study has been retracted. Here’s a link to my followup post.]